StockData
Atossa Therapeutics, Inc. logo

Atossa Therapeutics, Inc. (ATOS) stock

ATOSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.81−0.09 (-4.74%)

Close on Nov 18, 2026Market cap $18.06MP/E –Yield –

Atossa Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Atossa Therapeutics's profit margin for the twelve months ending Sep 30, 2016 was -500957.3%. For fiscal 2015 it was -896491.6%, against -36518.8% the year before. The highest annual figure on record is -1054.3% in fiscal 2012.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2015Dec 31, 2015-896491.6%−859972.8
FY2014Dec 31, 2014-36518.8%−34813.9
FY2013Dec 31, 2013-1704.9%−650.7
FY2012Dec 31, 2012-1054.3%+228430.3
FY2011Dec 31, 2011-229484.5%–

More Atossa Therapeutics figures

See a number that looks wrong?